* Required Fields
Salutation:
Select One
Dr.
Ms.
Mr.
First Name:
Last Name:
Requestor Type:
Select One
Patient/Consumer
Physician
Resident
Nurse
Pharmacist
Other Allied HCP
Email Address:
Phone:
xxx-xxx-xxxx
Fax:
xxx-xxx-xxxx
Address 1:
Address 2:
City:
Province:
Select One
Alberta
British Columbia
Manitoba
New Brunswick
Newfoundland and Labrador
Nova Scotia
Northwest Territories
Nunavut
Ontario
Prince Edward Island
Quebec
Saskatchewan
Yukon
Postal Code:
Product:
Select Product
BALVERSA™ (erdafitinib tablets)
CARIPUL® (epoprostenol for injection)
CARVYKTI™ (ciltacabtagene autoleucel)
CONCERTA® (methylphenidate HCl extended-release OROS tablets)
DARZALEX® (daratumumab)
DARZALEX® SC (daratumumab injection)
EDURANT® (rilpivirine)
ELMIRON® (pentosan polysulfate sodium)
EPREX® (epoetin alfa)
ERLEADA® (apalutamide tablets)
EVRA® (norelgestromin/ethinyl estradiol transdermal system)
IMBRUVICA® (ibrutinib)
INTELENCE® (etravirine)
INVEGA® (paliperidone)
INVEGA SUSTENNA® (paliperidone palmitate)
INVEGA TRINZA® (paliperidone palmitate)
Investigational Products
INVOKAMET® (canagliflozin-metformin)
INVOKANA® (canagliflozin)
JCOVDEN™ (COVID-19 Vaccine (Ad26.COV2-S [recombinant]))
OPSUMIT® (macitentan film-coated tablets)
OPSYNVI® (macitentan and tadalafil film-coated tablets)
PARIET® (rabeprazole sodium)
PONVORY™ (ponesimod)
PREZCOBIX® (darunavir/cobicistat)
PREZISTA® (darunavir tablets)
REMICADE® (infliximab)
RESOTRAN® (prucalopride succinate)
RISPERDAL CONSTA® (risperidone)
RYBREVANT® (amivantamab for injection)
SIMPONI® (golimumab injection)
SIMPONI I.V.® (golimumab for injection)
SPORANOX® (itraconazole)
SPRAVATO® (esketamine)
STELARA® (ustekinumab)
SYLVANT® (siltuximab)
SYMTUZA® (darunavir/cobicistat/emtricitabine/tenofovir alafenamide)
TECVAYLI™ (teclistamab injection)
TRACLEER® (bosentan monohydrate film-coated tablets)
TREMFYA® (guselkumab)
UPTRAVI® (selexipag film-coated tablets)
VELCADE® (bortezomib)
ZAVESCA® (miglustat capsules)
ZYTIGA® (abiraterone acetate)
General Inquiry - No Specific Product
Question:
Please indicate how you would prefer to receive this information:
e-mail
fax
mail
phone
Leave this field blank